NCT00006239View on ClinicalTrials.gov

Phenylbutyrate and Tretinoin in Treating Patients With Hematologic Cancer

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

December 31, 2000

Primary Completion Date

February 28, 2005

Study Completion Date

March 31, 2005

Conditions
LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Diseases
Interventions
DRUG

sodium phenylbutyrate

DRUG

tretinoin

Trial Locations (1)

21231-2410

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

OTHER

NCT00006239 - Phenylbutyrate and Tretinoin in Treating Patients With Hematologic Cancer | Biotech Hunter | Biotech Hunter